0001193125-26-209010
SEC filingRevenue grew 14% to $52.3M, driven by acquisitions and first aid sales, but operating income fell 28% as tariff costs and SG&A investments compressed margins.
Revenue for the first quarter of 2026 increased 13.8% to $52.3 million, compared to $46.0 million in the prior year period. The growth was primarily driven by the acquisition of the assets of My Medic and higher sales of first aid products. This performance reflects the company's strategic focus on expanding its product portfolio and market reach.
Gross profit increased 16.0% to $20.8 million, with gross margin improving to 39.7% from 39.0% in the prior year. The margin expansion was driven by favorable product mix, particularly from higher-margin first aid products. However, the company recognized higher tariff costs during the quarter as it sold inventory subject to elevated 2025 tariff rates. Management expects tariff impacts to gradually lessen over the balance of 2026 as lower-tariff inventory from November 2025 and February 2026 tariff adjustments is sold.
Management expects that the impact of tariffs on the company will gradually lessen over the balance of 2026 as the company begins to sell inventory subject to lower tariffs set in November 2025 and February 2026. However, the indirect impact on demand for the company's products as a result of these developments has become more uncertain.